Hostname: page-component-77c89778f8-vsgnj Total loading time: 0 Render date: 2024-07-18T03:02:49.295Z Has data issue: false hasContentIssue false
  • English
  • Français

Diagnosis and treatment of depression in patients with advanced illness

Published online by Cambridge University Press:  11 April 2011

Susan D. Block
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This article reviews common sources of suffering in patients with advanced illness, identifies challenges in appropriately diagnosing and treating depression in this setting, and examines the relationship between depression and other key clinical outcomes in the setting of advanced disease. A systematic literature review was conducted. Most of the existing research on patients with advanced illness has been conducted with cancer patients. Approximately 18 percent of patients with advanced illness meet criteria for major or minor depression; multiple psychiatric co-morbidities occur frequently. Prevalence rates increase as patients become sicker. However, depression is frequently underdiagnosed and undertreated in the setting of advanced illness. One of the key clinical challenges is differentiating depression from grief. Both psychosocial and psychopharmacologic interventions have been shown to be effective in treating depression in patients with advanced cancer. In conclusion, depression is a regular complication of advanced illness, reduces quality of life, compromises family member function, interferes with treatment decisions, and may shorten survival. However, numerous effective treatment approaches, including both medications and psychotherapy, exist and can be used to alleviate depression.

Type
Editorials
Information
Epidemiology and Psychiatric Sciences , Volume 19 , Issue 2 , June 2010 , pp. 103 - 109
Copyright
Copyright © Cambridge University Press 2010

References

Akechi, T., Okuyama, T., Sugawara, Y., Nakano, T., Shima, Y. & Uchitomi, Y. (2004). Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: associated and predictive factors. Journal of Clinical Oncology 22, 1957–1965.Google Scholar
Akechi, T., Okuyama, T., Onishi, J., Morita, T. & Furukawa, T.A. (2009). Psychotherapy for depression among incurable cancer patients (Review). Cochrane Library 4, i–23.Google Scholar
Alexopoulos, G.S., Katz, I.R., Reynolds, C.F III., Carpenter, D., Docherty, J.P. & Ross, R.W. (2001). Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines. Journal of Psychiatric Practice 7, 361–376.Google Scholar
Auret, K.A., Schug, S.A., Bremner, A.P. & Bulsara, M. (2009).randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. Journal of Pain Symptom Management 37, 613–621.Google Scholar
Ayres, A., Hoon, P.W., Franzoni, J.B., Matheny, K.B., Cotanch, P.H. & Takayanagi, S. (1994). Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. Journal of Psychosomatic Research 38, 393–402.CrossRefGoogle ScholarPubMed
Block, S.D. (2000). Assessing and managing depression in the terminally ill patient. Annals of Internal Medicine 132, 209–218.Google Scholar
Bosworth, H.B., McQuoid, D.R., George, L.K. & Steffens, D.C. (2002). Time-to-remission from geriatric depression: psychosocial and clinical factors. American Journal of Geriatric Psychiatry 10, 551–559.CrossRefGoogle ScholarPubMed
Breitbart, W., Bruera, E., Chochinov, H. & Lynch, M. (1995). Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. Journal of Pain Symptom Management 10, 131–141.Google Scholar
Breitbart, W., Rosenfeld, B., Kaim, M. & Funesti-Esch, J. (2001). A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Archives of Internal Medicine 161, 411–420.Google Scholar
Breslau, N., Roth, T., Rosenthal, L. & Andreski, P. (1996). Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults. Biological Psychiatry 39, 411–418.Google Scholar
Bruce, M.L., Ten Have, T.R., Reynolds, C.F. III., Katz, I.I., Schulberg, H.C., Mulsant, B.H., Brown, G.K., McAvay, G.J., Pearson, J.L. & Alexopoulos, G.S. (2004). Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. Journal of the American Medical Association 291, 1081–1091.Google Scholar
Burstein, H.J., Gelber, S., Guadagnoli, E. & Weeks, J.C. (1999). Use of alt4ernataive medicine by women with early-stage breast cancer. New England Journal of Medicine 340, 1733–1739.CrossRefGoogle ScholarPubMed
Caballero, J. & Nahata, M.C. (2005). Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV. Annals of Pharmacotherapy 39, 141–145.CrossRefGoogle ScholarPubMed
Cassem, E.H. (1999). Depressive disorders in the medically ill. (1999). An overview. Psychosomatics 36, S2–S10.Google Scholar
Chaturvedi, S.K., Maguire, P. & Hopwood, P. (1994), Antidepressant medications in cancer patients. Psycho-oncology 3, 57–60.CrossRefGoogle Scholar
Chochinov, H., Wilson, K., Enns, M & Lander, S. (1997). “Are you depressed?” Screening for depression in the terminally ill. American Journal of Psychiatry 154, 674–676.Google ScholarPubMed
Chochinov, H.M., Wilson, K.G., Enns, M., Mowchun, N., Lander, S., Levitt, M. & Clinch, J.J. (1995). Desire for death in the terminally ill. The American Journal of Psychiatry 152, 1185–1191.Google Scholar
Chochinov, H.M., Tataryn, D., Clinch, J.J.l. & Dudgeon, D. (1999). Will to live in the terminally ill. Lancet 354, 816–819.CrossRefGoogle Scholar
Ciaramella, A., & Poli, P. (2001). Assessment of depression among cancer patients: The role of pain, cancer type, and treatment. Psychooncology 10, 156–165.Google Scholar
Ciechanowski, P., Wagner, E., Schmaling, K., Schwartz, S., Williams, B., Diehr, P., Kulzer, J., Gray, S., Collier, C. & LoGerfo, J. (2004). Community-integrated home-based depression treatment in older adults: a randomized controlled trial. Journal of the American Medical Association 291, 1569–1577.Google Scholar
Cohen, L.M., Dobscha, S.K., Hails, K.C., Pekow, P.S. & Chochinov, H.M. (2002). Depression and suicidal ideation in patients who discontinue the life-support treatment of dialysis. Psychosomatic Medicine 64,889–896.Google Scholar
Dein, S. (2002). A place for psychostimulants in palliative care? Journal of Palliative Care 18, 196–199.CrossRefGoogle ScholarPubMed
Derogatis, L.R., Marrow, G.R., Fetting, J., Penman, D., Piasetsky, S., Schmale, A., Henrichs, M. & Carnicke, C.L.M. (1983). The prevalence of psychiatric disorders among cancer patients. Journal of the American Medical Association. 249, 751–757.Google Scholar
Emanuel, E.J., Fairclough, D.L. & Emanuel, L.L. (2000). Attitudes and desires related to euthanasia and physician-assisted suicide among terminally ill patients and their caregivers. Journal of the American Medical Association 284, 460–2468.Google Scholar
Evans, D.L., Staab, J.P., Petitto, J.M., Morrison, M.F., Szuba, M.P., Ward, H.E., Wingate, B., Luber, P. & Reardon, J. (1999). Depression in the medical setting: biopsychological interactions and treatment considerations. Journal of Clinical Psychiatry 60, Suppl. 4, 40–55.Google Scholar
Faller, H., Bulzebruck, H., Drings, P. & Lang, H. (1999). Coping, distress, and survival among patients with lung cancer. Archives of General Psychiatry 56, 756–762.CrossRefGoogle ScholarPubMed
Ferrando, S.J., Goldman, J.D. & Charness, W.E. (1997). Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms. General Hospital Psychiatry 19, 89–97.Google Scholar
Fisch, M.J., Loehrer, P.J., Kristeller, J., Passik, S., Jung, S.H., Shen, J., Arquette, M.A., Brames, M.J. & Einhorn, L.H. (2003). Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. Journal of Clinical Oncology 21, 1937–1943.CrossRefGoogle ScholarPubMed
Gibbs, J.S.R., Mc Coy, A.S.M., Gibbs, L.M.E., Rogers, A.E. & Addington-Hall, J.M. (2002). Living with and dying from heart failure: the role of palliative care. Heart 88, Suppl, ii36–ii39.Google Scholar
Goldberg, R.J. (1983). Systematic understanding of cancer patients who refuse treatment. Psychotherapy and Psychosomatics 39, 180–189.Google Scholar
Hotopf, M., Chidgey, J., Addington-Hall, J. & Ly, K.L. (2002). Depression in advanced disease: A systematic review. part 1. prevalence and case finding. Palliative Medicine 16, 81–97.Google Scholar
Jiang, W., Alexander, J., Christopher, E., Kuchibhatla, M., Gaulden, L.H., Cuffe, M.S., Blazing, M.A., Davenport, C., Califf, R.M., Krishnan, R.R. & O'Connor, C.M. (2001). Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Archives of Internal Medicine 161, 1849–1856.Google Scholar
Kadan-Lottick, N.S., Vanderwerker, L.C., Block, S.D., Zhang, B. & Prigerson, H.G. (2005). Psychiatric disorders and mental health service use in patients with advanced cancer: A report from the Coping with Cancer study. Cancer July (12) 2872–2881.CrossRefGoogle Scholar
Kissane, D.W. (2001). Demoralization syndrome – a relevant psychiatric diagnosis for palliative care. Journal of Palliative Care 17, 12–21.CrossRefGoogle ScholarPubMed
Koenig, H.G. (1998). Depression in hospitalized older patients with congestive heart failure. General Hospital Psychiatry 20, 29–43.Google Scholar
Lapid, M.I. & Rummans, T.A. (2003). Evaluation and management of geriatric depression in primary care. Mayo Clinic Proceedings 78, 1423–1429.Google Scholar
Lawrie, I., Lloyd-Williams, M. & Taylor, F. (2004). How do palliative medicine physicians assess and manage depression. Palliative Medicine 18, 234–238.CrossRefGoogle ScholarPubMed
Lebowitz, B.D. (1996). Diagnosis and treatment of depression in late life: an overview of the NIH consensus statement. American Journal of Geriatric Psychiatry 4, Suppl 1, S3–S6.Google Scholar
Lloyd-Williams, M. (2002). How common are thoughts of self-harm in a UK palliative care population? Support Care Cancer 10, 422–424.Google Scholar
Loberiza, F.R. Jr., Rizzo, J.D., Bredeson, C.N., Antin, J.H., Horowitz, M.M., Weeks, J.C. & Lee, S.J. (2002). Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. Journal of Clinical Oncology 20, 2118–2126.Google Scholar
Lundorff, L., Jønsson, B. & Sjøgren, P. (2009). Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomized, cross-over trial. Palliative Medicine doi: 10.1177/ 0269216309106872CrossRefGoogle Scholar
Macleod, A. (1989). Methylphenidate in terminal depression. Journal of Pain Symptom Management 16, 193–198.Google Scholar
Maltsberger, J.T. & Buie, D.H. (1974).Counter transference hate in the treatment of suicidal patients. Archives of General Psychiatry 30, 625–633.Google Scholar
Martire, L.M., Schulz, R., Reynolds, C.F. 3rd., Karp, J.F., Gildengers, A.G. & Whyte, E.M. (2010) Treatment of late-life depression alleviates caregiver burden. Journal of the American Geriatric Society; 58(1): 23–29.Google Scholar
Massie, M.J. (2004). Prevalence of depression in patients with cancer. Journal of the National Cancer Insitutet Monographs 32, 57–71.Google Scholar
McDaniel, J.S., Musselman, D.L., Porter, M.R., Reed, D.A. & Nemeroff, C.B. (1995). Depression in patients with cancer. diagnosis, biology, and treatment. Archives of General Psychiatry 52, 89–99.Google Scholar
Meyer, H.A.M., Sinnott, C. & Seed, P.T. (2003). Depressive symptoms in advanced cancer. part 2. depression over time; the role of the palliative care professional. Palliative Medicine 17, 604–607.Google Scholar
Meyer, H.A.M., Sinnott, C. & Seed, P.T. (2003). Depressive symptoms in advanced cancer. part 1. assessing depression: the mood evaluation questionnaire. Palliative Medicine 17, 596–603.Google Scholar
Moorey, S., Cort, E., Kapari, M., Monroe, B., Hansford, P., Mannix, K., Henderson, M., Fisher, L. & Hotopf, M. (2009). A cluster randomized controlled trial of cognitive behavior therapy for common mental disorders in patients with advanced cancer. Psychological Medicine 39, 713–723.CrossRefGoogle ScholarPubMed
Morrow, G.R., Hickok, J.T., Roscoe, J.A., Raubertas, R.F., Andrews, P.L., Flynn, P.J., Hynes, H.E., Banerjee, T.K., Kirshner, J.J. & King, D.K. (2003).Differential effects of paroxetine on fatigue and depression: a randomized double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Journal of Clinical Oncology 9, 477–488.Google Scholar
Mulsant, B.H., Alexopoulos, G.S., Reynolds, C.F. III., Katz, I.R., Abrams, R., Oslin, D. & Schulberg, H.C. (2001) Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm. International Journal of Geriatric Psychiatry 16, 585–592.CrossRefGoogle Scholar
Musselman, D.L., Lawson, D.H., Gumnick, J.F., Manatunga, A.K., Penna, S., Goodkin, R.S., Greiner, K., Nemeroff, C.B., & Miller, A.H. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alpha. New England Journal of Medicine 344, 961–966.Google Scholar
O'Connor, M.K., Knapp, R., Husain, M., Rummans, T.A., Petrides, G., Smith, G., Mueller, M., Snyder, K., Bernstein, H., Rush, A.J., Fink, M. & Kellner, C. (2001). The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. report. American Journal of Geriatric Psychiatry 9, 382–390.CrossRefGoogle ScholarPubMed
Olin, J. & Masand, P.S. (1996). Psychostimulants for depression in hospitalized cancer patients. Psychosomatics 37, 57–62.Google Scholar
Passik, S.D., Dugan, W., McDonald, M.V., Rosenfeld, B., Theobald, D.E., & Edgerton, S. (1998). Oncologists’ recognition of depression in their patients with cancer. Journal of Clinical Oncology 16, 1594–1600.CrossRefGoogle ScholarPubMed
Pelletier, G., Verhoef, M.J. & Khatri, N. & Hagan, N. (2002). Quality of life in brain tumor patients: The relative contributions of depression, fatigue, emotional distress, and existential issues. Journal of Neurooncology 57, 41–49.CrossRefGoogle Scholar
Pirl, W.F. & Roth, A.J. (1999). Diagnosis and treatment of depression in cancer patients. Oncology 13, 1293–1301.Google Scholar
Prigerson, H.G. & Jacobs, S.C. (2001). Perspectives on care the close of life. caring for bereaved patients: “all the doctors just suddenly go”. Journal of the American Medical Association 286, 1369–1376.Google Scholar
Quek, R., Morgan, J.A., George, S., Butrynski, J.A., Polson, K.M., Demetri, G.D. & Block, S.D. (2009). Small molecule tyrosine kinase inhibitors and depression. Journal of Clinical Oncology 27, 249–250.Google Scholar
Rabkin, J.G., McElhiney, M.C., Rabkin, R. & Ferrando, S.J. (2004). Modafinil treatment for fatigue in HIV+ patients: a pilot study. Journal of Clinical Psychiatry 65, 1688–1695.Google Scholar
Raison, C.L. & Miller, A.H. (2003). Depression in cancer: New developments regarding diagnosis and treatment. Biological Psychiatry 54, 283–294.Google Scholar
Raison, C.L. & Nemeroff, C.B. (2000). Cancer and depression: prevalence, diagnosis, and treatment. Home Health Care Consult 7, 34–41.Google Scholar
Ray, A., Block, S D., Friedlander, R., Zhang, B., Maciejewski, P K. & Prigerson, H. (2006). Peaceful awareness in advanced cancer patients. Journal of Palliative Medicine 9, 1359–1368.Google Scholar
Razavi, D., Allilaire, J., Smith, M., Salimpour, A., Verra, M., Desclaux, B., Saltel, P., Piollet, I., Gauvain-Piquard, A., Trichard, C., Cordier, B., Fresco, R., Guillibert, E., Sechter, D., Orth, J.-P., Bouhassira, M., Mesters, P. & Blin, P. (1996). The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatrica Scandinavica 94, 205–210.Google Scholar
Sollner, W., Zingg-Schir, M., Rumpold, G. & Fritsch, P. (1997). Attitude toward alternative therapy, compliance with standard treatment and need for emotional support in patients with melanoma. Archives of Dermatology 133, 316–321.Google Scholar
Spiegel, D. & Giese-Davis, J. (2003). Depression and cancer: mechanisms and disease progression. Journal of Biological Psychiatry 54, 269–282.CrossRefGoogle ScholarPubMed
Stommel, M., Given, B.A. & Given, C.W. (2002). Depression and functional status as predictors of death among cancer patients. Cancer 94, 2719–2727.Google Scholar
Theobald, D.E., Kirsh, K.L., Holtsclaw, E., Donaghy, K. & Passik, S.D. (2002). An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. Journal of Pain and Symptom Management 23, 442–447.Google Scholar
Theobald, D.E., Krish, K.L., Holtsclaw, E., Donaghy, K. & Passik, S.D. (2003). An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients. Palliative and Supportive Care 1, 71–77.CrossRefGoogle ScholarPubMed
Van Heeringen, K. & Zivkov, M. (1996). Pharmacological treatment of depression in cancer patients: A placebo-controlled study of mianserien. British Journal of Psychiatry 169, 440–443.Google Scholar
Van't Spijker, A., Trijsburg, R.W. & Duivenvoorden, H.J. (1997). Psychological sequelae of cancer diagnosis: A meta-analytical review of 58 studies after 1980. Psychosomatic Medicine 59, 280–293.Google Scholar
Verhoef, M.J., Hagen, N., Pelletier, G. & Forsyth, P. (1999). Alternative therapy use in neurologic diseases: use in brain tumor patients. Neurology 52, 617–622.Google Scholar
Wade, A., Crawford, G.M., Angus, M., Wilson, R. & Hamilton, L. (2003). A randomized, double-blind 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. International Clinical Psychopharmacology 18, 133–141.Google ScholarPubMed
Wagner, G.J. & Rabkin, R. (2000). Effects of dextroamphetamine on depression and fatigue in men with HIV: a double blind placebocontrolled trial. Journal of Clinical Psychiatry 61, 436–440.Google Scholar
Watkins, C., Daniels, L., Jack, C., Dickinson, H. & van den Broek, M. 2001). Accuracy of a single question in screening for depression in a cohort of patients after stroke; comparative study. British Medical Journal 323, 1159.Google Scholar
Williams, S. & Dale, J. (2006). The effectiveness of treatment for depression/ depressive symptoms in adults with cancer: as systematic review. British Journal of Cancer 94, 372–390.Google Scholar